Skip to main content

ENvue Medical, Inc.

FEED
Exchange
OTC
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
SEC CIK
0001326706

No open-market purchases or sales by ENvue Medical, Inc. insiders were filed in the last 90 days; 13 institutions reported holding it in 13F filings for Q2 2026, worth $149.2K in total; no superinvestor holds it.

13F holders, Q1 2021

Institutional positions in ENvue Medical, Inc. as of Mar 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
14
No complete 13F data for Q4 2020
Shares held
1.15M
No complete 13F data for Q4 2020
Total value
$1.17M
No complete 13F data for Q4 2020

Holders and value by quarter

Institutions reporting FEED on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2021: 14 institutions
Q1 2021: 14 institutionsQ2 2021: 17 institutionsQ3 2021: 21 institutionsQ4 2021: 20 institutionsQ1 2022: 19 institutionsQ2 2022: 13 institutionsQ3 2022: 15 institutionsQ4 2022: 18 institutionsQ1 2023: 10 institutionsQ2 2023: 9 institutionsQ3 2023: 13 institutionsQ4 2023: 11 institutionsQ1 2024: 10 institutionsQ2 2024: 8 institutionsQ3 2024: 9 institutionsQ4 2024: 9 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 6 institutionsQ4 2025: 6 institutionsQ1 2026: 13 institutionsQ2 2026: 13 institutions
Value heldQ1 2021: $1.17M
Q1 2021: $1.17MQ2 2021: $954.1KQ3 2021: $2.60MQ4 2021: $1.72MQ1 2022: $2.12MQ2 2022: $906.0KQ3 2022: $679.0KQ4 2022: $593.0KQ1 2023: $203.6KQ2 2023: $142.1KQ3 2023: $242.1KQ4 2023: $123.0KQ1 2024: $327.2KQ2 2024: $163.3KQ3 2024: $251.5KQ4 2024: $215.3KQ1 2025: $0Q2 2025: $0Q3 2025: $9.50KQ4 2025: $42.5KQ1 2026: $179.2KQ2 2026: $149.2K
Institutions holding FEED and their total value by quarter
QuarterHoldersValue
Q2 202613$149.2K
Q1 202613$179.2K
Q4 20256$42.5K
Q3 20256$9.50K
Q2 20250$0
Q1 20250$0
Q4 20249$215.3K
Q3 20249$251.5K
Q2 20248$163.3K
Q1 202410$327.2K
Q4 202311$123.0K
Q3 202313$242.1K
Q2 20239$142.1K
Q1 202310$203.6K
Q4 202218$593.0K
Q3 202215$679.0K
Q2 202213$906.0K
Q1 202219$2.12M
Q4 202120$1.72M
Q3 202121$2.60M
Q2 202117$954.1K
Q1 202114$1.17M

Institutions, Q1 2021

Shares, value and share of portfolio for each institution holding ENvue Medical, Inc..

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.

Institutions holding FEED in Q1 2021
InstitutionSharesValue% of portfolioChange in sharesAction
Renaissance Technologies LLC318,500$325.0K0.00%––
Vanguard Group Inc191,677$196.0K0.00%––
Amtrust Financial Services, Inc.146,148$149.0K0.10%––
Citadel Advisors LLC137,590$139.0K0.00%––
Geode Capital Management, LLC99,383$100.0K0.00%––
HighTower Advisors, LLC92,552$94.0K0.00%––
UBS Group AG54,917$56.0K0.00%––
Virtu Financial LLC52,067$53.0K0.00%––
Northern Trust Corp19,043$19.0K0.00%––
Two Sigma Advisers, LP15,000$15.0K0.00%––
Jacobi Capital Management LLC15,000$15.0K0.00%––
Psagot Investment House Ltd.9,720$10.0K0.00%––
Wells Fargo & Company141$00.00%––
Tower Research Capital LLC (TRC)91$00.00%––